4.6 Article

Development and Validation of a Risk Stratification System for Pulmonary Embolism After Elective Primary Total Joint Arthroplasty

期刊

JOURNAL OF ARTHROPLASTY
卷 31, 期 9, 页码 S187-S191

出版社

CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
DOI: 10.1016/j.arth.2016.02.080

关键词

venous thromboembolism; pulmonary embolism; total hip arthroplasty; total knee arthroplasty; prophylaxis

向作者/读者索取更多资源

Introduction: Stratification of patients into different risk categories for pulmonary embolism (PE) after total joint arthroplasty (TJA) may allow clinicians to individualize venous thromboembolism prophylaxis based on an appropriate risk-benefit scale. Methods: Patients undergoing primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) as part of the American College of Surgeons National Surgical Quality Improvement Program were identified. Independent risk factors for PE within 30 days of surgery were identified and used to develop a point-scoring system to estimate the relative risk for PE. For validation, the systemwas tested on patients undergoing TJA at a single institution. Results: A total of 118,473 patients were identified, including 72,673 (61.3%) undergoing TKA and 45,800 (38.7%) undergoing THA. The incidence of PE within 30 days of the index arthroplasty was 0.50%. The risk factors associated with PE were age >= 70, female gender, higher body mass index (25-30 kg/m(2) and >= 30 kg/m2), and TKA (vs THA); anemia was protective. The point scores derived for each of these factors were as follows: anemia: -2; female: +1; body mass index 25-30 kg/m2: +2; body mass index >= 30 kg/m2: +3; age >= 70 years: +3; TKA: +5. The point-scoring system was then applied to 17,384 patients from a single institution. Single-institution patients categorized as low risk using the point-scoring system had a 0.44% 90-day risk for PE (95% CI = 0.29%-0.58%); medium risk, 1.51% (95% CI = 1.18%-1.84%); and high risk, 2.60% (95% CI = 2.09%-3.10%). Conclusion: This point-scoring system predicts risk for PE after TJA and may help surgeons to optimize selection of chemical prophylaxis. (c) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据